Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jon Greenberg"'
Autor:
Yasong Lu, Shuang Liang, Ying Hong, Naoyuki Tajima, Kashyap Patel, Hanbin Li, David R. Wada, Jon Greenberg, Adam Petrich, Hong Zebger‐Gong, Dale Shuster, Pavan Vaddady
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 1, Pp 23-28 (2024)
Abstract To replace the conventional maximum tolerated dose (MTD) approach, a paradigm for dose optimization and dose selection that relies on model‐informed drug development (MIDD) approaches has been proposed in oncology. Here, we report our appl
Externí odkaz:
https://doaj.org/article/07375fb147c347daba609e818c44fe7c
Autor:
Paul R Barber, Rami Mustapha, Fabian Flores-Borja, Giovanna Alfano, Kenrick Ng, Gregory Weitsman, Luigi Dolcetti, Ali Abdulnabi Suwaidan, Felix Wong, Jose M Vicencio, Myria Galazi, James W Opzoomer, James N Arnold, Selvam Thavaraj, Shahram Kordasti, Jana Doyle, Jon Greenberg, Magnus T Dillon, Kevin J Harrington, Martin Forster, Anthony CC Coolen, Tony Ng
Publikováno v:
eLife, Vol 11 (2022)
Background: Advanced head and neck squamous cell carcinoma (HNSCC) is associated with a poor prognosis, and biomarkers that predict response to treatment are highly desirable. The primary aim was to predict progression-free survival (PFS) with a mult
Externí odkaz:
https://doaj.org/article/f01407f956a24b9e8f9a0385ed5d4e28
Autor:
Hamim Zahir, Ophelia Yin, Ching Hsu, Andrew J. Wagner, Jason Jiang, Xiaoning Wang, Jon Greenberg, Dale E. Shuster, Tarundeep Kakkar, Frank LaCreta
Publikováno v:
Clinical Pharmacology in Drug Development. 12:475-483
Autor:
Kenrick Ng, Giovanna Alfano, Fabian Flores-Borja, Rami Mustapha, Paul R Barber, Gregory Weitsman, Luigi Dolcetti, Ali Abdulnabi Suwaidan, Felix Wong, Jose M Vicencio, Myria Galazi, James W Opzoomer, James N Arnold, Selvam Thavaraj, Shahram Kordasti, Jana Doyle, Jon Greenberg, Magnus T Dillon, Kevin J Harrington, Martin Forster, Anthony CC Coolen, Tony Ng
Publikováno v:
Elife, 11, 1-22
Elife, 11, pp. 1-22
Elife, 11, pp. 1-22
Background:Advanced head and neck squamous cell carcinoma (HNSCC) is associated with a poor prognosis, and biomarkers that predict response to treatment are highly desirable. The primary aim was to predict progression-free survival (PFS) with a multi
Autor:
Kenrick Ng, Giovanna Alfano, Fabian Flores-Borja, Rami Mustapha, Paul R Barber, Gregory Weitsman, Luigi Dolcetti, Ali Abdulnabi Suwaidan, Felix Wong, Jose M Vicencio, Myria Galazi, James W Opzoomer, James N Arnold, Selvam Thavaraj, Shahram Kordasti, Jana Doyle, Jon Greenberg, Magnus T Dillon, Kevin J Harrington, Martin Forster, Anthony CC Coolen, Tony Ng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c57c8dff8d520f1ca78e5f702a5e2731
https://doi.org/10.7554/elife.73288.sa2
https://doi.org/10.7554/elife.73288.sa2
Autor:
Magnus T. Dillon, Giovanna Alfano, Jose Miguel Vicencio, Shahram Kordasti, Rami Mustapha, Paul R. Barber, Martin Forster, James W. Opzoomer, Kevin J. Harrington, James N. Arnold, Myria Galazi, Gregory Weitsman, Tony Ng, Luigi Dolcetti, Kenrick Ng, Jon Greenberg, Anthony C. C. Coolen, Fabian Flores-Borja, Felix Wong, Jana Doyle
BackgroundAdvanced Head and Neck Squamous Cell Cancer (HNSCC) is associated with a poor prognosis, and biomarkers that predict response to treatment are highly desirable. The primary aim was to predict Progression Free Survival (PFS) with a multivari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e79651a6efe64429ee9f46cd394e9429
https://doi.org/10.1101/2021.09.22.21263942
https://doi.org/10.1101/2021.09.22.21263942
Publikováno v:
Chest. 160:A733
Autor:
Jon Greenberg
The Chicago Cubs are one of the most historic teams in Major League Baseball, and their World Series championship in 2016 will forever remain one of baseball's iconic triumphs. In If These Walls Could Talk: Chicago Cubs, Jon Greenberg of The Athletic
Autor:
Martin Sebastian, Dietrich Hadler, Maciej Krzakowski, Robert A. Beckman, Joachim von Pawel, Ewa Chmielowska, Jon Greenberg, Qiang Wang, Tara Fox, Martin Reck
Publikováno v:
Lung Cancer. 82:441-448
Introduction Tigatuzumab, a humanized monoclonal DR5 agonist antibody induces apoptosis in human cancer cell lines. The objective of this study was to investigate the antitumor effects of tigatuzumab combined with carboplatin/paclitaxel in chemothera
Autor:
Jon Greenberg
Publikováno v:
SIGGRAPH Dailies